A device developed by a Georgia Tech biomedical engineering professor that uses artificial intelligence (AI) to improve the treatment process for those with structural heart disease received FDA clearance in June.
Precision TAVI is an (AI)-driven individualized computer predictive modeling tool that can be used to improve patient outcomes, enhanced lifetime planning, and reduced costs associated with treating those needing transcatheter aortic valve replacement.
Lakshmi (Prasad) Dasi, a professor in the Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Tech, is the founder and chief technology officer for Dasi Simulations, the company behind the Precision TAVI.
“DASI Simulations empowers every heart team with critical insights guaranteeing the identification of the best possible care for individual patients, customized to their unique circumstances and anatomy, Dasi said. “One surgery at a time, our technology helps avoid complications, repeated interventions, helps lifelong planning for optimal structural heart care, and has the potential to save billions in unnecessary costs from preventable complications.”
Latest BME News
Georgia Tech authors reflect a rapidly evolving field in new edition highlighting real-world applications
Hands-on approach to teaching microfluidics is inspiring future innovators
In this edition of Ferst Exchange, Coulter BME's Aniruddh Sarkar explains the science.
Georgia Tech researchers uncover the role of lateral inhibition in enhancing contrast and filtering distractions, with implications for neuroscience and AI.
Graduate BME students are tackling heart disease and training to become leaders and innovators in cardiovascular research
BME undergrad is first student from Coulter department and one of three from Georgia Tech to earn aerospace honor
Coulter BME researchers develop 3D-printed, bioresorbable heart valve, potentially eliminating the need for repeated surgeries.
